about
Brain tumorsPerfusion magnetic resonance imaging: a comprehensive update on principles and techniquesDW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastomaPretargeted Positron Emission Tomography Imaging That Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal ChemistryNitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.Classic models for dynamic contrast-enhanced MRI.Structural optimization of Zn(II)-activated magnetic resonance imaging probes.Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.Surgical management of high-grade glioma: a standard of care.Imaging biomarkers in primary brain tumours.Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat modelUse of the ODD-luciferase transgene for the non-invasive imaging of spontaneous tumors in mice.Molecular imaging of gliomas with PET: opportunities and limitations.PORTR: Pre-operative and post-recurrence brain tumor registrationIntra-operative 3-T MRI for paediatric brain tumours: challenges and perspectives.Antiangiogenic therapy for glioblastoma: current status and future prospects.Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides.Multiparametric magnetic resonance imaging of brain disorders.Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasionGlioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.Imaging Tumor Vascularity and Response to Anti-Angiogenic Therapy Using Gaussia LuciferaseImaging tumor burden in the brain with 89Zr-transferrinIn vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma.Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior.Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis.Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.Multiparametric MRI and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma.Evaluating novel radiation techniques for the treatment of cerebral metastases.Correlation of (18)F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool.Quantitative MR perfusion parameters related to survival time in high-grade gliomas.Quantitative magnetisation transfer imaging in glioma: preliminary results.Glioma grading using apparent diffusion coefficient map: application of histogram analysis based on automatic segmentation.Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.Automated Modular Magnetic Resonance Imaging Clinical Decision Support System (MIROR): An Application in Pediatric Cancer Diagnosis.
P2860
Q24605136-7FBD94CF-6990-47AE-84BB-AC0979CE5C93Q27012911-5B5AEB25-5027-4E02-9B21-5E5807B776C8Q28730443-40EEF0DB-0186-4FD1-8507-D3DCD875C6B5Q28829134-534061DE-96AB-4CE8-A993-44F07B2F4BE7Q30431810-CD13D6B6-7A0A-4D85-9207-967DF68FE6AEQ30626277-031BA88E-8FD9-4CD1-937F-1E66E26CBA8AQ30650060-764C8F80-7AF2-402F-B947-5FB0D83933FCQ30651792-6A440D81-A5A8-4745-80E9-EAD93CB4EC96Q30818733-25E53FB5-211F-46A0-92AF-58D9BCFA6DCCQ30838365-1217E3FD-008E-4F95-9904-5E959DB7B286Q30880129-F288B345-DF30-4828-9434-A7C73D9F0B76Q31065446-E60D9F01-11AA-4B58-9410-CD3E46C31A3BQ33616603-6896A55C-620F-42BD-AEE4-E057034DD9B9Q33867525-AE7D9517-6D95-454C-8D77-E98AEAEA9C1EQ33961188-FBC8BBB0-095A-4CD8-8D89-B25284715485Q34049922-CFCD16DA-7ADE-4165-8AC0-3F05D793FAAFQ34144004-BB6919EA-6FD2-4539-B5CE-2D5EF516116AQ34523319-63AC3A45-806E-4C45-BF22-8A7710FF2998Q34681190-5D6683B3-DD15-4C43-9A55-51610E681F31Q35870173-A90DF57E-DC62-4693-A2AB-83CF6C6631B2Q35895174-130D1F10-C696-4294-8F87-0E0E55D8C09CQ35914515-E4E3223B-46AA-430B-8C87-133F9C2C90C2Q36847792-AC01DA7D-8E5F-4A15-A77B-5FC1254419C9Q36919260-4F0D9B61-9E3C-415A-AEED-312DA556D081Q37106244-71168714-2868-4AB4-BCDE-6F7114A99B5DQ37674285-F13A6D27-5EE1-4AE9-A6B0-F2CA2A66EB7FQ38964679-CA01B8EE-49D4-4D96-A939-6091AA346625Q39624333-0EA3E43A-6920-4F71-B0D2-8FA2D2D9A820Q40052515-DCE57CF5-C906-40AC-B568-21E0F8F2C769Q40360133-C54F0671-A7AC-44A0-A132-A721D7D90E79Q41462863-C33AC36D-94C7-4DDC-8EA1-32D0B9833E7AQ41854870-B61C8403-B5B1-4855-8B25-A45704FB8F35Q42022095-674F9273-6BCB-4DAC-B632-0E423BCBFF36Q43860815-3C247B0E-0FC1-4146-B8E5-C7669F12893CQ46070994-826F067F-61E5-41B4-94F9-EFE63B0635EEQ46626243-DFCD5832-3DC9-4CCD-A545-B7F85DA4797EQ48662054-C9BA5444-5DD7-4F6C-81E9-39B71A1DA4B3Q55346991-25AEF844-79D4-4300-B507-5A3564BACE7F
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quantitative imaging biomarkers in neuro-oncology.
@ast
Quantitative imaging biomarkers in neuro-oncology.
@en
type
label
Quantitative imaging biomarkers in neuro-oncology.
@ast
Quantitative imaging biomarkers in neuro-oncology.
@en
prefLabel
Quantitative imaging biomarkers in neuro-oncology.
@ast
Quantitative imaging biomarkers in neuro-oncology.
@en
P2093
P2860
P50
P1476
Quantitative imaging biomarkers in neuro-oncology.
@en
P2093
Alan Jackson
Christopher A Clark
Jeremy H Rees
National Cancer Research Institute Brain Tumour Imaging Subgroup
Thomas C Booth
P2860
P304
P356
10.1038/NRCLINONC.2009.92
P407
P577
2009-06-23T00:00:00Z